Brain-derived neurotrophic factor levels in newly diagnosed patients with bipolar disorder, their unaffected first-degree relatives and healthy controls
Open Access
- 16 February 2021
- journal article
- research article
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 7 (2), e55
- https://doi.org/10.1192/bjo.2021.9
Abstract
Brain-derived neurotrophic factor (BDNF), which facilitates neuroplasticity and synaptogenesis, may be decreased in bipolar disorder, but has not been systematically investigated in people with newly diagnosed bipolar disorder and unaffected first-degree relatives. To compare BDNF levels in patients with newly diagnosed bipolar disorder, their unaffected first-degree relatives and healthy controls. The study investigated plasma BDNF levels in patients (n = 371) with newly diagnosed bipolar disorder, their unaffected first-degree relatives (n = 98) and healthy controls (n = 200) using enzyme-linked immunosorbent assay. We further investigated associations between BDNF levels and illness-related variables and medication status. BDNF levels were found to be 22.0% (95% CI 1.107–1.343) higher in patients with bipolar disorder compared with healthy controls (P < 0.001) and 15.6% higher in unaffected first-degree relatives compared with healthy controls (95% CI 1.007–1.327, P = 0.04), when adjusting for age and gender. Further, BDNF levels were positively associated with duration of illness at a trend level (P = 0.05), age (P = 0.001) and use of anti-epileptic medication (P = 0.05). These findings suggest that BDNF levels are not decreased in the early stages of bipolar disorder and in unaffected first-degree relatives contrasting with prior findings during later stages of the illness.This publication has 30 references indexed in Scilit:
- Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)Molecular Psychiatry, 2013
- Treatment in a specialised out-patient mood disorder clinicv.standard out-patient treatment in the early course of bipolar disorder: randomised clinical trialThe British Journal of Psychiatry, 2013
- Diagnostic and Statistical Manual of Mental DisordersPsychiatry Research, 2011
- Serum brain-derived neurotrophic factor: Determinants and relationship with depressive symptoms in a community population of middle-aged and elderly peopleThe World Journal of Biological Psychiatry, 2011
- The BDNF Val66Met polymorphism: Relation to familiar risk of affective disorder, BDNF levels and salivary cortisolPsychoneuroendocrinology, 2009
- Role of BDNF in bipolar and unipolar disorder: Clinical and theoretical implicationsJournal of Psychiatric Research, 2007
- The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neuronsMolecular Psychiatry, 2007
- The impact of age, weight and gender on BDNF levels in human platelets and plasmaNeurobiology of Aging, 2005
- Transport of brain-derived neurotrophic factor across the blood–brain barrierNeuropharmacology, 1998
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978